Tag: Zymergen

Sumitomo Chemical partners with Zymergen on new multi-year specialty materials deal

Sumitomo Chemical partners with Zymergen on new multi-year specialty materials deal

April 17, 2019 |

In California, Sumitomo Chemical and Zymergen announced they have signed a multi-year partnership to bring new specialty materials to the market. This collaboration between the two companies will enable the development of new materials to meet consumer trends in high-tech industries. Today, electronics makers and consumers seek devices that are lighter, smaller, more battery efficient, […]

Read More

Last Train to Emeryville: The DigiBio value engine is leavin’ the station, are you on it?

Last Train to Emeryville: The DigiBio value engine is leavin’ the station, are you on it?

January 9, 2018 |

Tie-ins for Zymergen, Radiant Genomics, DMC, Capricorn Venture Partners, Syngenta and CHS demonstrate the firepower and scope of digital biology. Today, products made via traditional biological tools tap into easy-to-grow-in-a-lab organisms, and mostly nothin’ else. Sort of like making all the wines in the world from Merlot grapes, because the underlying manufacturing is just too easy […]

Read More

Zymergen gets Lit: raises $130M in epic Series B

Zymergen gets Lit: raises $130M in epic Series B

October 11, 2016 |

In California, Zymergen has raised $130 million in Series B funding led by SoftBank Group. The round also includes prior lead investor Data Collective (DCVC), as well as return investors True Ventures, AME Cloud Ventures, DFJ, Innovation Endeavors, Obvious Ventures, and Two Sigma Ventures. New investors include Iconiq Capital, Prelude Ventures, and Tao Capital Partners. […]

Read More

Arzeda, Zymergen ink pact to develop advanced, novel molecules

Arzeda, Zymergen ink pact to develop advanced, novel molecules

March 28, 2016 |

In Washington state, Zymergen and Arzeda have signed a multi-year agreement to develop strains and processes to manufacture novel, high utility molecules and materials utilizing Arzeda’s pathway and enzyme design and Zymergen’s strain construction capabilities. “The development of new materials was a major driver of technological development over the course of the 20th century.  Biology has the […]

Read More

Technology, biology, automation, computation: The Digest’s 2015 8-Slide Guide to Zymergen

Technology, biology, automation, computation: The Digest’s 2015 8-Slide Guide to Zymergen

December 3, 2015 |

What’s Zymergen? As they put it, “We believe in harnessing the power of biology to make transformative products that are good for business, people and the environment. By applying the latest in automation, data architecture and machine learning, we’re making better microbes for use in industrial fermentation. Bottom line, they engineer strains for partners, helping […]

Read More

The Hottest Companies in the Advanced Bioeconomy: Winning Photo Votes for October 13, 2015

The Hottest Companies in the Advanced Bioeconomy: Winning Photo Votes for October 13, 2015

October 13, 2015 |

Here are the winning Photo Votes for the week in this years’s competition for the Hottest Companies in the Advanced Bioeconomy. This week, with the Hot 40 roaring swiftly to a close, we’re focused on Hot 40 Photo Votes. All Hot 50 photo votes for this week will join the competition next week. “There’s nothing like […]

Read More

The Hottest Companies in the Advanced Bioeconomy: Zymergen Photo Votes for 2015-16

The Hottest Companies in the Advanced Bioeconomy: Zymergen Photo Votes for 2015-16

October 5, 2015 |

Here are the photo votes received for Zymergen in this years’s competition for the Hottest Companies in the Advanced Bioeconomy. More on photo voting in this years’ rankings process, here.

Read More

Zymergen lands $44M in monster Series A venture round

Zymergen lands $44M in monster Series A venture round

June 17, 2015 |

What just happened? First of a new generation of bioeconomy wonders now counts Jerry Yang, Max Levchin, Eric Schmidt funds as investors’ and “several Fortune 100 companies” among its customers. Today, the Zymergen story, so far, can now be told. And we look at potential roadblocks down the road for this new class of companies coming […]

Read More